No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
This video was recorded during the ESC Congress 2020.
Prof. Verheugt - cardiologist in Amsterdam, The Netherlands
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: